Issues
-
Cover Image
Cover Image
Representative images of the rapid infiltration by CD11b+ myeloid cells into 54A lung carcinoma tissue at 2 days after local irradiation of 21 Gray. Images are maximum intensity projections of tissue sections analyzed by confocal microscopy. Myeloid cells are shown in green (identified by CD11b immunostaining), and blood vessels are shown in red (identified by CD31 immunostaining); in blue, DAPI nuclear staining. Scale bar, 100μm. For details, see the article by Kozin and colleagues on page 5679 of this issue. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
AACR Centennial Series
Review
Priority Reports
PIK3CA Mutations in In situ and Invasive Breast Carcinomas
Integrated Systems and Technologies
Microenvironment and Immunology
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Molecular and Cellular Pathobiology
DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis
Therapeutics, Targets, and Chemical Biology
Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
A Useful Approach to Identify Novel Small-Molecule Inhibitors of Wnt-Dependent Transcription
Tumor and Stem Cell Biology
Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
Letters to the Editor
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.